Digital manufacturing company Carbon (Redwood City, CA) has introduced its first medical-grade material: Medical Polyurethane 100 (MPU 100). This white polymer resin combines mechanical strength, biocompatibility and sterilizability, making it suitable for the fabrication of medical components used in skin- and drug-contact devices and single-use applications.
MPU 100 offers a solution for producing end-use parts such as complex adaptors for diagnostic analysis systems, textured instrument handles, single-use instruments and bioprocessing components. Each of these applications brings distinct manufacturing opportunities, such as targeting better user experiences with complex geometries and textured surfaces, consolidating multi-part assemblies into one printed part and pursuing a more customized portfolio with low-volume, high-mix part production, said Carbon. The combination of high-performance MPU 100 with Carbon’s Digital Light Synthesis (DLS) technology allows medical device manufacturers and life sciences companies to accelerate product development pathways for critical devices and components.
“With MPU 100, Carbon is enabling new capabilities for medical device manufacturers by providing the mechanical properties, biocompatibility, sterilization compatibility and chemical resistance to produce safe and reliable end-use products for patients,” said Jason Rolland, Vice President of Materials. “The life sciences and medical device industries show enormous promise for using 3D printing for production at scale, and we will continue to prioritize the development of next-generation materials in this segment.”